Hsuan-Chieh Liao

Hsuan-Chieh Liao

Auto-generated profile, based on publicly available information

Hsuan-Chieh Liao

Departments of Laboratory Medicine and Pathology, University of Washington , Seattle, WA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in The Journal of Pediatrics
Verified
Journal Article
Closed access
MCMin-Ju Chan
Min-Ju Chan
HLHsuan-Chieh Liao
Hsuan-Chieh Liao
MGMichael H. Gelb
Michael H. Gelb
CCChih-Kuang Chuang
Chih-Kuang Chuang
MLMei-Ying Liu
Mei-Ying Liu
CCChuan-Chi Chiang
Chuan-Chi Chiang

Verified
Journal Article
Open access
PDF file
Michael GelbMichael Gelb
Michael Gelb
KBKhaja Basheeruddin
Khaja Basheeruddin
alberto burlinaalberto burlina
alberto burlina
HCHsiao-Jan Chen
Hsiao-Jan Chen
YCYin-Hsiu Chien
Yin-Hsiu Chien
DMDietrich Matern
Dietrich Matern
Tandem mass spectrometry (MS/MS) is the most universal platform currently available for the analysis of enzymatic activities and biomarkers in dried blood spots (DBS) for applications in newborn screening (NBS). Among the MS/MS applications in NBS, the most common is flow-injection analysis (FIA-) MS/MS, where the sample is introduced as a bolus injection into the mass spectrometer without the prior fractionation of analytes. Liquid chromatography combined with MS/MS (LC-MS/MS) has been employed for second-tier tests to reduce the false-positive rate associated with several nonspecific screening markers, beginning two decades ago. More recently, LC-MS/MS has been applied to primary screening for new conditions for which FIA-MS/MS or other methods, including genomic screening, are not yet adequate. In addition to providing a list of the currently used LC-MS/MS-based assays for NBS, the authors share their experience regarding the maintenance requirements of LC-MS/MS vs. FIA-MS/MS systems. The consensus is that the maintenance of LC-MS/MS and FIA-MS/MS instrumentation is similar, and LC-MS/MS has the advantage of allowing for a larger number of diseases to be screened for in a multiplex, cost-effective fashion with a high throughput and an adequate turnaround time.

Verified
Journal Article
Open access
PDF file
ZHZackary Michel Herbst
Zackary Michel Herbst
Leslie UrdanetaLeslie Urdaneta
Leslie Urdaneta
Terri L. KleinTerri L. Klein
Terri L. Klein
Barbara K. BurtonBarbara K. Burton
Barbara K. Burton
KBKhaja Basheeruddin
Khaja Basheeruddin
Michael GelbMichael Gelb
Michael Gelb
All newborn screening (NBS) for mucopolysaccharidosis-I and -II (MPS-I and MPS-II) is carried out via the measurement of α-iduronidase (IDUA) and iduronate-2-sulfatase (IDS) enzymatic activity, respectively, in dried blood spots (DBS). The majority of low enzyme results are due to pseudodeficiencies, and data from recent MPS-II population screenings and studies from the Mayo Clinic show that the false positive rate can be dramatically reduced by the inclusion of a second-tier analysis of glycosaminoglycans (GAGs) in DBS as part of NBS. In the present study, which focused on MPS-II, we obtained newborn DBS from 17 patients with severe MPS-II, 1 with attenuated MPS-II, and 6 patients with various IDS pseudodeficiencies. These samples were submitted to two different GAG mass spectrometry analyses in a comparative study: (1) internal disaccharide biomarkers and (2) endogenous biomarkers. For both of these methods, the biomarker levels in six patients with pseudodeficiencies were below the range measured in MPS-II patients. One patient with attenuated MPS-II was not distinguishable from severe disease patients, but all MPS-II patients were distinguishable from the reference range using both methods. The minimal differential factor (lowest GAG marker level in MPS-II samples divided by highest level in the reference range of 60 random newborns) was 3.01-fold for the internal disaccharide method. The endogenous biomarker method demonstrated an improved minimum differential of 5.41-fold. The minimum differential factors between MPS-II patients and patients with pseudodeficiencies for the internal disaccharide and endogenous biomarker methods were 3.77-fold and 2.06-fold, respectively. This study supports use of the second-tier GAG analysis of newborn DBS, especially the endogenous disaccharide method, as part of NBS to reduce the false positive rate.


9 August 2023 in Journal of Analytical Toxicology
Verified
Journal Article
Closed access
PDF file
RWRebecca J Wilson
Rebecca J Wilson
TLThomas J Laha
Thomas J Laha
GBGeoffrey S Baird
Geoffrey S Baird
AHAndrew N Hoofnagle
Andrew N Hoofnagle
HLHsuan-Chieh Liao
Hsuan-Chieh Liao
To the Editor, Chronic pain management programs typically utilize urine drug testing to ensure patient compliance and to detect diversion or misuse, which can result in treatment discontinuation. The interpretation of urine drug test results can be challenging, particularly with respect to potential interferences or exposure to opioid-containing foods, like poppy seed-containing products ( 1). Current guidelines suggest that urinary codeine concentrations exceeding 300 ng/mL, along with a morphine-to-codeine ratio <2, are most consistent with codeine use, ruling out poppy seed ingestion ( 2). However, recent studies have challenged these guidelines by demonstrating high codeine concentrations and low morphine-to-codeine ratios in various food products ( 3). Furthermore, our toxicology laboratory has recently received many samples with high concentrations of codeine and its glucuronide metabolite from patients who deny codeine use and attribute their results to poppy seed-containing foods. As a result, we aimed to provide additional information on the effects of the consumption of poppy seed-containing foods on screening and confirmatory urine opioid test results.

17 March 2023 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KCKa Keung Chan
Ka Keung Chan
AMAndrea J. Moore
Andrea J. Moore
AHAndrew N. Hoofnagle
Andrew N. Hoofnagle
GBGeoffrey S. Baird
Geoffrey S. Baird
HLHsuan-Chieh Liao
Hsuan-Chieh Liao